Ashley Attaway
Adult Health · Mansfield, TXNPI 1487353876
Payments from drug & device makers
Across 51 payments — averaging $24.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$236
- Novo Nordisk$189
- GSK$131
- Medtronic$108
- Lilly USA, LLC$102
- Pfizer$101
- plus $359 from 11 others
What the payments were for
- Food & beverage$1,226100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $236 |
| Novo Nordisk | 4 | $189 |
| GSK | 7 | $131 |
| Medtronic | 1 | $108 |
| Lilly USA, LLC | 6 | $102 |
| Pfizer | 5 | $101 |
| Abiomed | 2 | $93 |
| AstraZeneca | 4 | $74 |
| Sanofi-aventis U.S. LLC | 2 | $42 |
| Bayer | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Exact Sciences | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$108
How this compares
$1,226 in reported general payments places this provider in the 65th percentile of 933 adult health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 35 | $256 |
| Methylprednisolone | 28 | $183 |
| Rosuvastatin Calcium | 14 | $117 |
| Sertraline Hcl | 15 | $99 |
| Losartan Potassium | 14 | $95 |
| Azithromycin | 26 | $78 |
| Citalopram HbrCitalopram Hydrobromide | 13 | $43 |
| Amlodipine Besylate | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other adult health in Mansfield
- Misty SheddAllen$863K
- Melodie YoungDallas$700K
- Cynthia BedellPlano$168K
- Elizabeth Wedberg SivamAustin$71K
- Mary SalazarSan Antonio$68K
- Eric KlappholzDallas$44K
- Christin TouchetKingwood$43K
- Yulia LyuboslavskyAustin$36K
- Meghan MurphyAustin$29K
- Sandra CareyGrapevine$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.